
    
      A pilot study of Dextran-40 infusion in decompensated cirrhotic patients complicating with
      AKI. Dextran-40Â® was administered at 1 g/kg/day for two days. AKI reversal was defined when
      serum creatinine was < 1.5 mg/dL. Albumin infusion was given if AKI reversal did not occur.
    
  